AU2001270200A1 - Fatty acid synthase inhibitors - Google Patents
Fatty acid synthase inhibitorsInfo
- Publication number
- AU2001270200A1 AU2001270200A1 AU2001270200A AU7020001A AU2001270200A1 AU 2001270200 A1 AU2001270200 A1 AU 2001270200A1 AU 2001270200 A AU2001270200 A AU 2001270200A AU 7020001 A AU7020001 A AU 7020001A AU 2001270200 A1 AU2001270200 A1 AU 2001270200A1
- Authority
- AU
- Australia
- Prior art keywords
- fatty acid
- acid synthase
- synthase inhibitors
- inhibitors
- fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000015303 Fatty Acid Synthases Human genes 0.000 title 1
- 108010039731 Fatty Acid Synthases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21428000P | 2000-06-27 | 2000-06-27 | |
| US60214280 | 2000-06-27 | ||
| PCT/US2001/020458 WO2002000646A1 (en) | 2000-06-27 | 2001-06-27 | Fatty acid synthase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001270200A1 true AU2001270200A1 (en) | 2002-01-08 |
Family
ID=22798484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001270200A Abandoned AU2001270200A1 (en) | 2000-06-27 | 2001-06-27 | Fatty acid synthase inhibitors |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US6608059B1 (en) |
| AU (1) | AU2001270200A1 (en) |
| WO (1) | WO2002000646A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820682B2 (en) | 2002-10-03 | 2010-10-26 | Ono Pharmaceutical Co., Ltd. | LPA receptor antagonist |
| AU2005311826A1 (en) * | 2004-11-30 | 2006-06-08 | Plexxikon, Inc. | Indole derivatives for use as PPAR active compounds |
| WO2006090817A1 (en) * | 2005-02-25 | 2006-08-31 | Ono Pharmaceutical Co., Ltd. | Indole compound and use thereof |
| EP1943245A2 (en) * | 2005-09-07 | 2008-07-16 | Plexxikon, Inc. | 1,3-disubstituted indole derivatives for use as ppar modulators |
| CN101117328B (en) * | 2006-08-01 | 2012-11-07 | 中国人民解放军军事医学科学院毒物药物研究所 | Fatty acid synthetase inhibitor and application for treating bacterial infection |
| PE20090159A1 (en) * | 2007-03-08 | 2009-02-21 | Plexxikon Inc | INDOL-PROPIONIC ACID DERIVED COMPOUNDS AS PPARs MODULATORS |
| AR072297A1 (en) | 2008-06-27 | 2010-08-18 | Novartis Ag | DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE. |
| TWI469965B (en) | 2008-12-22 | 2015-01-21 | Ono Pharmaceutical Co | Ethynylindole compounds |
| WO2011066211A1 (en) * | 2009-11-24 | 2011-06-03 | Glaxosmithkline Llc | Azabenzimidazoles as fatty acid synthase inhibitors |
| US8450350B2 (en) | 2010-05-05 | 2013-05-28 | Infinity Pharmaceuticals, Inc. | Triazoles as inhibitors of fatty acid synthase |
| EP2566853B1 (en) | 2010-05-05 | 2017-01-25 | Infinity Pharmaceuticals, Inc. | Tetrazolones as inhibitors of fatty acid synthase |
| MY162757A (en) | 2010-06-21 | 2017-07-14 | Ono Pharmaceutical Co | New Crystalline Forms of 4,4’-[4-Fluoro-7-({4-[4-(3-Fluoro-2-Methylphenyl) Butoxy] Phenyl}Ethynyl)-2-Methyl-1H-Indole-1, 3-Diyl] Dibutanoic Acid |
| US20130196971A1 (en) * | 2010-09-17 | 2013-08-01 | Christopher Joseph Aquino | Fatty acid synthase inhibitors |
| HUE045701T2 (en) | 2013-03-13 | 2020-01-28 | Forma Therapeutics Inc | 2-Hydroxy-1- {4 - [(4-phenylphenyl) carbonyl] piperazin-1-yl} ethan-1-one derivatives and related compounds as fatty acid synthase (FASN) inhibitors for the treatment of cancer |
| WO2017165497A1 (en) | 2016-03-22 | 2017-09-28 | Leof Edward B | Using fatty acid synthase inhibitors to treat fibrosis |
| TWI767148B (en) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | Inhibiting fatty acid synthase (fasn) |
| WO2020092395A1 (en) | 2018-10-29 | 2020-05-07 | Forma Therapeutics, Inc. | SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1 H-BENZO[d]IMIDAZOL-5-YL)BENZOYL) PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL109311A0 (en) * | 1993-04-16 | 1994-07-31 | Lilly Co Eli | 1H-indole-3-acetamide sPla2 inhibitors |
| FR2745003B1 (en) * | 1996-02-16 | 1998-04-03 | Adir | NOVEL PSEUDOPEPTIDES DERIVED FROM NEUROKININS, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US6486211B1 (en) * | 1999-10-22 | 2002-11-26 | Smithkline Beecham Corporation | Indole compounds |
-
2001
- 2001-06-27 US US10/296,774 patent/US6608059B1/en not_active Expired - Fee Related
- 2001-06-27 AU AU2001270200A patent/AU2001270200A1/en not_active Abandoned
- 2001-06-27 WO PCT/US2001/020458 patent/WO2002000646A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002000646A1 (en) | 2002-01-03 |
| US6608059B1 (en) | 2003-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001258771A1 (en) | -secretase inhibitors | |
| IL153230A0 (en) | Liposomal benzoquinazoline thymidylate synthase inhibitor formulations | |
| AU2001270200A1 (en) | Fatty acid synthase inhibitors | |
| AU2001278986A1 (en) | 3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors | |
| AU2001281059A1 (en) | Fatty acid synthase inhibitors | |
| AU2001236052A1 (en) | Urease inhibitors | |
| AU2001280167A1 (en) | Novel propenohydroxamic acid derivatives | |
| AU2002222627A1 (en) | Tak1 inhibitors | |
| AU7961300A (en) | Kainic acid neurocytotoxicity inhibitors | |
| IL148324A0 (en) | Fatty acid synthase inhibitors | |
| AU2001271531A1 (en) | Fatty acid synthase inhibitors | |
| AU2003902413A0 (en) | Modification of fatty acid biosynthesis | |
| AU2002224550A1 (en) | Corrosion inhibitors | |
| GB0030284D0 (en) | Enzyme inhibitors | |
| AU2002243439A1 (en) | Fatty acid synthase inhibitors | |
| AU2001274940A1 (en) | Fatty acid synthase inhibitors | |
| IL151250A0 (en) | Difluorobutyric acid metalloprotease inhibitors | |
| AU6925500A (en) | Fatty acid synthase inhibitors | |
| AU2001271718A1 (en) | Fatty acid synthase inhibitors | |
| AU6926500A (en) | Fatty acid synthase inhibitors | |
| AU2001291160A1 (en) | Fatty acid synthase inhibitors | |
| AU2001284705A1 (en) | Fatty acid synthase inhibitors | |
| AUPQ851000A0 (en) | Rapid fatty acid delivery | |
| AU2001268853A1 (en) | Biocatalyst inhibitors | |
| AU2001269121A1 (en) | Substituted amidoalkyl-uracils as parp inhibitors |